Key Takeaways STXS released first clinical data on MAGiC catheter showing safety and efficacy in arrhythmia procedures. STXS' catheter showed 94% acute efficacy with low adverse event rates across 67 patients. MAGiC offers improved stability and precision, boosting confidence in STXS' robotic ablation tech.Stereotaxis (STXS) recently announced the publication of initial clinical results from its MAGiC catheter in the Journal of Interventional Cardiac Electrophysiology. The study, titled “First In-Human Re ...